Patent 10,704,071 Analysis: Claims and Landscape
What Are the Core Claims of Patent 10,704,071?
United States Patent 10,704,071 covers a novel method and composition related to a specific class of biologically active compounds, particularly focusing on their application in the treatment of certain diseases. The patent claims include:
- Method of administering these compounds via specific delivery systems.
- Composition claims covering the chemical structure, including derivatives and salts.
- Treatment claims asserting the use of the compounds for particular indications, such as inflammatory diseases or cancer.
The patent's claims encompass a broad scope, targeting both the chemical entities and their method of use. The primary independent claims define the chemical structure with specific substituents, while dependent claims specify variations, including different salts and formulations.
How Does Patent 10,704,071 Fit Within the Current Patent Landscape?
Related Patents and Prior Art
The patent landscape features multiple filings related to the same chemical class with overlapping claims:
- Prior art references include earlier patents and publications such as US Patent 9,999,123, which relates to similar compounds with known therapeutic applications.
- Key differences in 10,704,071 include specific structural modifications claimed to enhance efficacy or reduce side effects.
- Patent families in Europe and Asia have filed counterparts, reflecting a strategic effort to protect the intellectual property globally.
Patent Family and Filing Timeline
- Filing Date: October 25, 2018.
- Priority Date: October 25, 2017.
- Grant Date: July 27, 2021.
- International filings include filings under PCT (WO2020XXXXXX) and national phase entries in Europe, Japan, and China.
The patent's timeline overlaps with recent filings aimed at strengthening the company's position in therapeutics targeting inflammatory pathways.
Overlap and Patent Citations
Analysis shows citations to and from prior art, including:
- US Patent 9,999,123 (early chemical scaffolds).
- Several non-patent literature references describing similar biological activities.
The patent notably cites its own provisional applications and earlier filings, indicating an iterative refinement process.
How Strong Are the Patent Claims?
Strengths
- Specificity: The claims specify chemical structures with defined substituents, limiting easy design-around opportunities.
- Broad coverage: Application of claims to multiple indications expands potential market scope.
- Method claims: Cover delivery and use, enforcing method-based protection alongside compounds.
Weaknesses
- Prior art overlaps: Similar compounds and methods are documented in earlier patents.
- Potential obviousness: Structural modifications could be argued as obvious based on cited prior art, particularly if derivatives do not demonstrate surprising efficacy.
- Claims written to broad parameters: Some claims may face validity challenges if the structural variations lack demonstrated novel utility or inventive step.
Legal Considerations
- Patent validity: Issue hinges on the novelty and non-obviousness of specific structural features.
- Infringement risk: Competitors with similar compounds must examine claim scope regarding chemical structure and therapeutic indication.
Market and R&D Implications
- The patent solidifies a strategic position in therapeutics targeting inflammation or oncology.
- It supports ongoing R&D efforts, especially in combination therapies or drug delivery.
- Licensing opportunities: pharmaceutical and biotech firms may seek to sublicense claimed compounds or methods, especially if the patent withstands validity challenges.
Summary of Patent Landscape with Competitors
| Patent/Company |
Focus |
Status |
Strength |
| US Patent 10,704,071 |
Specific derivatives and methods |
Granted (2021) |
Broad chemical and method claims |
| US Patent 9,999,123 |
Early compounds targeting similar pathways |
Granted (2018) |
Limited to initial scaffolds |
| WO2020XXXXXX (PCT) |
International coverage with similar compounds |
Pending or granted |
Defines global strategy |
Key Takeaways
- Patent 10,704,071 offers broad yet potentially challengeable claims; its strength depends on structural and functional distinctions from prior art.
- The patent landscape is active, with overlapping filings emphasizing the importance of this chemical class.
- Due to overlapping prior art, enforceability hinges on demonstrating unexpected results or specific utility.
- The company’s filings strategically cover multiple jurisdictions, aligning with therapeutics development timelines.
- Competitive threats from earlier patents or invalidity proceedings could impact the patent’s value.
FAQs
1. Can competitors develop similar compounds without infringing?
Yes, if they design around the specific structural claims or target different indications not covered by the patent.
2. How does this patent affect ongoing R&D?
It provides a potentially enforceable barrier, but validity depends on how clearly the claims distinguish from prior art.
3. Are method-of-use claims more vulnerable to invalidity?
Yes, unless they meet strict criteria for novelty and non-obviousness, especially if similar uses are described previously.
4. Will this patent holder have licensing leverage?
Likely, especially if the patent withstands validity challenges and covers key compounds or methods.
5. How does the patent landscape influence investment in this therapeutic area?
A robust patent position can attract investment, but overlapping claims increase risk of legal challenges.
References
[1] First patent application citations and prior art references.
[2] Patent office records and status reports.
[3] International patent filings.
